Don't miss a thing!
OUR NEWS AND VIEWS
SHARING LATEST
DEVELOPMENTS AND INSIGHTS
Here we report on topics relating to digital medical publishing and our business. These include our research reports, whitepapers and thought-leadership, as well as our latest programmes, engagement insights, industry partnerships and team recruits.
May 2023
Growth Hormone Deficiency Learning Zone launches on Medthority
HCPs will gain understanding of growth hormone deficiency and appropriate treatment options after engaging with this educational programme, developed independently of sponsor Sandoz.
View the Learning ZoneMay 2023
Programme goes live: Anti-CGRP therapies for migraine
Developed with an educational grant from Pfizer, this Learning Zone includes focus on the unmet needs and disease burden associated with migraine and anti-CGRP therapies for acute and prophylactic treatment.
View the Learning ZoneApr 2023
Harnessing the power of omnichannel for impactful HCP engagement
Are you making best use of available channels to deliver meaningful engagement with HCPs? In this article, we offer insight on the building blocks for an effective omnichannel approach.
READ ARTICLEFeatured article
Thought Leadership
Creating an award-winning HCP engagement platform
EPG Health’s pioneering approach to…
Jan 2023
Mar 2023
The evolution of medical congress – where next?
Following the emergence of the hybrid congress model, EPG Health shares expert insight into the future of scientific meetings and opportunities that have surfaced to expand their reach far beyond in-person attendance.
READ ARTICLEFeb 2023
Programme launch: Weight control in type 2 diabetes
With an educational grant from Eli Lilly & Company, EPG Health has launched an independent Learning Zone (featuring KOL videos) to enhance disease awareness and educate HCPs on treatment and strategies for prevention.
View the Learning ZoneFeb 2023
Launch of mCRPC Learning Zone on Medthority
Developed independently of sponsor Pfizer, this programme details unmet needs in the management of metastatic castration-resistant prostate cancer and potential ways to meet them, featuring expert opinion from KOLs and congress highlights.
View the Learning Zone